Altraz

Altraz tablet is primarily used for managing breast cancer in postmenopausal women. This medicine falls under the category of aromatase inhibitors, a group of medicines that function by minimising oestrogen levels in the body.
In addition to its main use, this tablet also plays a significant role as an adjuvant in the early stage hormone receptor-positive breast cancer treatment. It can be employed alone or in combination with other therapies such as surgery or radiation therapy. Moreover, it is a first-line medication for advanced or metastatic hormone receptor-positive or hormone receptor-unknown breast cancer management in postmenopausal women.